TCF7L2 and metabolic syndrome: In participants with < 7% weight gain during the follow-up, the multivariable-adjusted HRs (95% CI) for the MetS risk across tertiles of nut consumption according to both TCF7L2 rs7903146 and rs12255372 genotypes are presented in Table 4.